researchdrivelogo.jpg
Global Cancer Stem Cells Market to Surpass $1,898.3 Million, Growing with a CAGR of 11.8% from 2019 to 2026, Post-COVID-19 Disaster by Research Dive
17 août 2021 09h02 HE | Research Dive
New York, USA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- A newest report on the global cancer stem cells market has been added by Research Dive to its repository. The report presents exhaustive insights on...
researchdrivelogo.jpg
Global Cancer Stem Cells Market to Witness Exponential Growth Owing to the Rising Efficiency of Stem Cell Therapy – Informative Report [180 Pages] by Research Dive
02 août 2021 09h00 HE | Research Dive
New York, USA, Aug. 02, 2021 (GLOBE NEWSWIRE) -- A recently published report by Research Dive states that the global cancer stem cells market is expected to witness a rise in revenue from $786.3...
ResearchDriveLogo.jpg
Global Cancer Stem Cells Market to Boost with CAGR of 11.8% and Cross a Margin of $1,898.3 Million During the Covid-19 Outbreak – Exclusive Report [150 Pages] by Research Dive
08 déc. 2020 09h05 HE | Research Dive
New York, USA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The cancer stem cells market is anticipated to grow rapidly in the Covid-19 outbreak due to usage of cancer stem cells for treating cancer. According...
Reports and Data.jpeg-01
Cancer Stem Cells Market To Reach USD 2.18 Billion By 2027 | Reports and Data
14 mai 2020 11h06 HE | Reports and Data
New York, May 14, 2020 (GLOBE NEWSWIRE) -- The global Cancer Stem Cells market is forecast to reach USD 2.18 Billion by 2027, according to a new report by Reports and Data. The market for stem cells...
ResearchDriveLogo.jpg
Cancer Stem Cell Market Projected to Garner a Revenue of $ 1,722.7 million at a CAGR of 10.3% by 2026
13 févr. 2020 18h45 HE | Research Dive
New York, USA, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The global cancer stem cell market is estimated to reach $ 1,722.7 million by 2026 from $786.3 million in 2018 at a CAGR of 10.3% during the forecast...
Logo-BCC-Research.jpg
Global Cancer Stem Cell Market to Reach Nearly $2B by 2022
17 janv. 2018 12h29 HE | BCC Research
WELLESLEY, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer stem cells have been found in a range of human tumors and are potential targets for cancer treatment. The global cancer stem cell...
OncoMed Pharmaceuticals, Inc. Logo
OncoMed Announces Multiple Abstracts Related to Anti-TIGIT Program Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2017
02 mars 2017 08h30 HE | OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) will present new data related to its clinical and preclinical immuno-oncology and anti-cancer stem...
National Brain Tumor Society Cites Ten Reasons for Brain Tumor Community Excitement in 2017
10 janv. 2017 17h35 HE | National Brain Tumor Society
BOSTON, MA--(Marketwired - January 10, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community, enters 2017 with greater enthusiasm about its mission...
OncoMed Pharmaceuticals, Inc. Logo
OncoMed Presents Phase 1b Data for First-in-Class Treatments in Ovarian, Breast and Lung Cancer at the 2016 ASCO Annual Meeting
05 juin 2016 09h00 HE | OncoMed Pharmaceuticals, Inc.
First Presentation of Combination Data for Wnt Inhibitors, Ipafricept and Vantictumab Updated Data for Demcizumab and Tarextumab Also Presented CHICAGO and REDWOOD CITY, Calif., June 05, 2016 ...
OncoMed Pharmaceuticals, Inc. Logo
OncoMed Pharmaceuticals Reports Third Quarter 2015 Financial Results
05 nov. 2015 07h00 HE | OncoMed Pharmaceuticals, Inc.
REDWOOD CITY, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel cancer stem cell (CSC) and immuno-oncology...